Peak6 Investments LLC Guardant Health, Inc. Transaction History

Peak6 Investments LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	BUY	$20.94 - $38.01 $125,598 - $227,983	5,998 New	5,998 $214,000
Q4 2022 Feb 10, 2023	BUY	$25.44 - $59.78 $373,001 - $876,494	14,662 New	14,662 $399,000
Q4 2021 Feb 11, 2022	BUY	$88.71 - $120.43 $700,720 - $951,276	7,899 Added 394950.0%	7,901 $790,000
Q4 2020 Feb 12, 2021	SELL	$99.96 - $135.93 $11,995 - $16,311	-120 Reduced 98.36%	2 $0
Q3 2020 Nov 13, 2020	SELL	$80.32 - $111.8 $31,646 - $44,049	-394 Reduced 76.36%	122 $13,000
Q2 2020 Aug 14, 2020	SELL	$60.49 - $97.5 $112,390 - $181,155	-1,858 Reduced 78.26%	516 $42,000
Q1 2020 May 14, 2020	SELL	$59.04 - $88.81 $481,589 - $724,423	-8,157 Reduced 77.46%	2,374 $165,000
Q4 2019 Feb 13, 2020	SELL	$59.49 - $82.78 $1.82 Million - $2.53 Million	-30,614 Reduced 74.41%	10,531 $823,000
Q3 2019 Nov 08, 2019	BUY	$62.59 - $110.3 $2.16 Million - $3.8 Million	34,485 Added 517.79%	41,145 $2.63 Million
Q2 2019 Aug 14, 2019	BUY	$63.94 - $91.11 $425,840 - $606,792	6,660 New	6,660 $575,000

324

127M

844K

2.38M

Ticker GH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 102,220,000
Market Cap $3.59B
Description
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...

Get notified when there are updates to the investment portfolio of Peak6 Investments LLC, based on Form 13F filings with the SEC.

Stay updated on Peak6 Investments LLC with notifications on news.